Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P1.03-005 - Phase 2 Study of Ceritinib in Patients with ALK+ NSCLC with Prior Alectinib Treatment in Japan: ASCEND-9
09:30 - 09:30 | Presenter: Hidehito Horinouchi | Author(s): M. Maemondo, T. Hida, M. Takeda, K. Hotta, F. Hirai, Y.H. Kim, S. Matsumoto, Tetsuya Mitsudomi, Takashi Seto, S. Moizumi, K. Tokushige, B. Hatano, Makoto Nishio
- Abstract
Loading...
-
+
P2.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P2.03-036 - Comparing the Efficacy/Toxicity of Osimertinib and First Line EGFR-TKI by Individual Patient Analysis
09:30 - 09:30 | Presenter: Shoko Narita | Author(s): Yasushi Goto, J. Sato, R. Morita, S. Murakami, Shintaro Kanda, Hidehito Horinouchi, Y. Fujiwara, N. Yamamoto, Yuichiro Ohe
- Abstract
Loading... -
+
P2.03-048 - Mixed Response of Non-Small Cell Lung Cancer Harboring the EGFR T790M Mutation to Osimertinib
09:30 - 09:30 | Presenter: Yuki Shinno | Author(s): Yasushi Goto, J. Sato, R. Morita, Y. Matsumoto, S. Murakami, Shintaro Kanda, Hidehito Horinouchi, Y. Fujiwara, N. Yamamoto, Yuichiro Ohe
- Abstract
Loading...
-
+
P2.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P2.07-011 - Long Follow up from Phase I Study of Nivolumab and Chemotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
09:30 - 09:30 | Presenter: Shintaro Kanda | Author(s): Yuichiro Ohe, Y. Matsumoto, S. Murakami, Yasushi Goto, Hidehito Horinouchi, Y. Fujiwara, H. Nokihara, N. Yamamoto, T. Yamamoto, T. Tamura
- Abstract
Loading...
-
+
MA 10 - Immunotherapy I
- 11:00 - 12:30
- 10/17/2017
- Location: Room 303 + 304
- Type: Mini Oral
- Track: Immunology and Immunotherapy
- Moderators:S. Wang, Robert Pirker
-
+
MA 10.08 - Discussant - MA 10.05, MA 10.06, MA 10.07
11:45 - 12:00 | Presenter: Hidehito Horinouchi
- Abstract
No abstract available for this presentation
-
+
MA 16 - Mediastinal, Tracheal and Esophageal Tumor: Multimodality Approaches
- 15:45 - 17:30
- 10/17/2017
- Location: Room 313 + 314
- Type: Mini Oral
- Track: Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
- Moderators:K. Shibuya, Francoise Mornex
-
+
MA 16.04 - Phase II Trial of S-1 Treatment as Palliative-Intent Chemotherapy for Previously Treated Advanced Thymic Carcinoma
16:00 - 16:05 | Presenter: Fumiyoshi Ohyanagi | Author(s): Y. Okuma, Yasushi Goto, K. Sunami, Y. Nakahara, S. Kitazono, Y. Tambo, N. Yanagitani, Shintaro Kanda, A. Horiike, Hidehito Horinouchi, Y. Fujiwara, H. Nokihara, N. Yamamoto, Makoto Nishio, Yuichiro Ohe, Y. Hosomi
- Abstract
Loading...
-
+
P3.02 - Biology/Pathology
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Biology/Pathology
-
+
P3.02-041 - EGFR Amplification Mediates Resistance to TAS121, A Third-Generation EGFR-TKI, in EGFR T790M-Positive Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Sho Watanabe | Author(s): Yasushi Goto, N. Motoi, Takashi Kohno, J. Sato, R. Morita, S. Kanda, Hidehito Horinouchi, Y. Fujiwara, H. Nokihara, N. Yamamoto, Yuichiro Ohe
- Abstract
Loading...
-
+
P3.04 - Clinical Design, Statistics and Clinical Trials
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Clinical Design, Statistics and Clinical Trials
-
+
P3.04-002 - A Randomized Phase II Study of Carboplatin plus Nab-Paclitaxel with or Without Nintedanib for NSCLC with IPF (J-SONIC): Trial in Progress
09:30 - 09:30 | Presenter: Kohei Otsubo | Author(s): J. Kishimoto, Hirotsugu Kenmotsu, Y. Minegishi, Eiki Ichihara, A. Shiraki, Terufumi Kato, Shinji Atagi, Hidehito Horinouchi, M. Ando, Y. Kondoh, Masahiko Kusumoto, K. Ichikado, Nobuyuki Yamamoto, Yoichi Nakanishi, Isamu Okamoto
- Abstract
Loading...
-
+
MS 23 - Management of N2 NSCLC: What “Operable” Means?
- 14:30 - 16:15
- 10/18/2017
- Location: F203 + F204 (Annex Hall)
- Type: Mini Symposium
- Track: Locally Advanced NSCLC
- Moderators:G. Lyons, Marc De Perrot
-
+
MS 23.03 - What is Resectable N2 Disease, and What is Unresectable N2 Disease: A Medical Oncologist's Viewpoint
15:10 - 15:30 | Presenter: Hidehito Horinouchi
- Abstract
Loading...